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CHAPTER 2: RESULTS AND DISCUSSION 































hydroxy-1H-benzotriazole	 as	 well	 as	 6-chloro-1-hydroxy-1H-benzotriazole	 under	
established	conditions	and	moderate	to	high	yields	of	products	were	isolated.		Obtained	N-
oxides	were	 then	deoxygenated	using	 tetrahydroxydiboron	 (B2(OH)4)	 in	MeCN,	 following	
previously	established	conditions.		N-Oxides	resulting	from	the	reactions	of	5,6-dichloro-1H-
hydroxybenzotriazole	were	 difficult	 to	 purify	 and	 prone	 to	 degradation.	 To	 alleviate	 the	
problem,	a	 two-step	one-pot	 reaction	was	designed.	 	After	N-arylation	was	complete	and	
without	any	further	purification,	the	reduction	step	was	performed	using	B2(OH)4	in	MeCN.	
The	method	proved	beneficial	for	the	reaction	with	phenylboronic	acid,	and	no	significant	









fused	 to	 a	 benzene	 ring.	 	 They	 can	 contain	 substituents	 on	 the	 aromatic	 ring	 or	 on	 the	
nitrogen	 ring.	 	They	are	one	of	 the	most	 important	 groups	of	heterocyclic	 compounds	 in	

























for	 treatment	 of	 postmenopausal	 breast	 cancer.	 	 It	 causes	 reversible	 inhibition	 of	





inhibits	 the	 growth	 of	 Gram-positive	 bacteria,	 Gram-negative	 bacteria,	 and	 fungi,	 with	
results	 superior	 when	 compared	 to	 the	 synthesized	 precursors.14	 	 N1-alkylated	
benzotriazoles	are	also	known	to	have	a	high	bonding	affinity	to	a	wide	range	of	proteins	
such	 as	 tyrosine	 kinase.15	 	 Examples	 of	 other	 benzotriazole	 derivatives	 with	 medicinal	
applications	are	shown	in	Figure	1.		
Apart	 from	 their	 biological	
activities,	 benzotriazolyl	
derivatives	 have	 also	 found	
applications	in	other	industries.		In	
agriculture,	 they	 are	 used	 as	
herbicides,16-a	 insecticides,16-b	 and	
acaricides.16-c	 	 They	 are	 also	 used	















































tolyl	 benzotriazole	 are	 found	 to	 be	 the	 primary	 agents	 in	 most	 types	 of	 aircraft	






































































Historically,	 the	 first	published	reports	of	benzotriazoles	appeared	 in	1934	and	1935,	
when	 Fries27	 and	 Fieser28	 independently	 reported	 the	 synthesis	 of	 1H-benzotriazole	 via	
multi-step	synthesis,	in	relatively	low	yields.		It	was	not	until	1940	that	a	successful	one-step	
synthesis	of	1H-benzotriazole	was	reported	in	the	literature.29		Damschrodner	and	Peterson	
were	 able	 to	 synthesize	 the	 1H-benzotriazole	 in	 a	 high	 yield	 (80%)	 by	 nitrosation	 of	 o-











































































of	 their	 medicinal	 and	 biological	 activities.	 	 Singh	 et	 al.,	 reported	 that	 N-acridinyl	
benzotriazoles	 displayed	 antibacterial	 activity.31	 	 Since	 both	 acridine	 and	 benzotriazole	
themselves	exhibit	medicinal	properties	in	multiple	contexts,	the	authors	hypothesized	that	




increased	 activity	was	 observed	when	 the	 C-2	 position	 of	 acridine	was	 substituted	with	
either	an	–OCH3	or	–CH3		(Figure	3,	second	from	the	left).		
For	centuries	malaria	has	been	a	major	health	problem	in	tropical	countries.		To	this	day	
it	 remains	 dangerous,	 causing	 over	 a	 million	 deaths	 each	 year.32	 	 For	 many	 years,	
chloroquine	 has	 been	 used	 as	 the	 only	 synthetic	 drug	 against	 malaria.	 	 However,	 the	
Plasmodium	 falciparum	 parasite	 that	 causes	 malaria	 has	 become	 resistant	 to	 the	 drug,	
causing	the	need	for	discovery	of	new,	potent	antimalarial	drug.		This	problem	was	alleviated	
to	 some	 extent	 with	 the	 use	 of	 4-chlorochalcone	 and	 2,4-dichlorochalcone	 substituted	
benzotriazole	derivatives,	which	showed	antiplasmoidal	activity	against	P.	falciparum	and	



















this	 reason,	 the	 inhibition	 of	 JNK	 potentially	 has	 therapeutic	 application.	 	 Multiple	
synthesized	 molecules	 showed	 good	 inhibition	 of	 JNK1,	 with	 superior	 results	 when	
compared	 to	 the	 inhibition	 of	 JNK2.	 	 Also,	 the	 1,2,3-benzotriazole	 derivative	 showed	








































N-Arylated	 benzotriazoles	 have	 also	 found	 applications	 in	 areas	 outside	 of	 the	














































Selectfluor	 in	nitromethane	 at	120	 oC.	 	Antilla	et	 al.	 reported	 a	 selective	N-1	 arylation	of	
benzotriazoles	with	aryl	iodides	using	CuI,	N,N’-dimethyl-1,2-cyclohexyldiamine,	and	K3PO4	
in	 toluene	 at	 110	 oC	 (equation	 3	 in	 Scheme	 3).43	 	 However,	 when	 the	 N-arylation	 of	
benzotriazoles	 with	 aryl	 halides	 was	 carried	 out	 using	 CuBr2,	 TBAF	 at	 145	 oC,	 the	
regioselectivity	was	lost	and	both	N-1	and	N-2	arylated	products	were	observed	(equation	4	
in	Scheme	3).44		In	addition	to	the	copper-mediated	N-arylation	of	benzotriazoles,	palladium-
catalyzed	 synthesis	 of	 N-arylated	 benzotriazoles	were	 also	 investigated.	 	 One	 such	 study	
showed	 that	N-arylated	 benzotriazoles	 could	 be	 synthesized	 by	 Pd(OAc)2-catalyzed	 C–H	
bond	activation	of	aryl	triazenes	in	presence	of	Cs2CO3	under	O2	atmosphere	(equation	5	in	
Scheme	3).45		Although,	C–H	bond	activation	was	preferred	on	unsubstituted	aryl	groups,	in	
the	 case	 of	 unsymmetrical	 triazenes,	 under	 these	 conditions,	 significant	 amounts	 of	
regioisomeric	products	were	also	observed.	 	An	alternative	approach	 for	 the	synthesis	of	
regioselective	N-arylated	benzotriazoles	was	reported	by	Zhou	et	al.	where	N-methyl-N-aryl-
N’-bromoaryl	 triazenes	were	 cyclized	using	Pd(OAc)2,	 dppp,	 and	KOAc	 in	DMF	at	 110	 oC	
(equation	6	in	Scheme	3).46		The	cyclization	takes	place	via	a	1,7-palladium	migration	by	the	
C–H	 bond	 activation	 followed	 by	 dealkylative	 cyclization.	 	 Despite	 the	 successful	
methodologies	for	the	synthesis	of	N-arylated	benzotriazoles,	some	methods	require	harsh	





















































+ ArX CuBr2TBAF, 








































formation	 of	N-arylated	 benzotriazoles	 (Scheme	 4).	 	 In	 the	 cases	 where	 unsymmetrical	





aryl	 benzotriazoles.35,49	 	Within	 this	 category	 Chen	 and	 Buchwald	 designed	 a	 three-step	
reaction	 for	 the	 synthesis	 of	N-arylated	 benzotriazoles	 from	 2-chloronitrobenzenes	 and	
aromatic	amines.50		Formation	of		the	C–N	bond	using	iPr2NEt	at	160–180	oC	was	followed	














































In	 2008,	 Shi	 et	 al.	 reported	 a	 general	method	 for	 synthesis	 of	 substituted	N-arylated		
benzotriazoles	 via	 a	 1,3-dipolar	 cycloaddition	 of	 benzynes	 with	 azides,	 under	 mild	
conditions	(equation	1	 in	Scheme	7).51	 	They	were	able	 to	obtain	high	yields	with	a	wide	
range	 of	 azides	 and	 o-(trimethylsilyl)phenyl	 triflate,	 using	 CsF	 to	 generate	 the	 aryne,	 in	
acetonitrile	as	the	solvent.		Zhang	and	Moses	used	a	similar	strategy	and	synthesized	N-aryl		
benzotriazoles,	but	 in	a	one-pot	approach	by	generating	aryl	 azides	 in	 situ	 from	anilines,	
followed	 by	 the	 1,3-dipolar	 cycloaddition	 with	 benzynes	 (equation	 2	 in	 Scheme	 7).52		
Another	approach	utilizes	1,3-dipolar	cycloaddition	using	1,5-diynes	and	NaN3.	 	Although	
high	yields	were	obtained,	the	designed	method	required	multiple	steps	to	synthesize	the	












1) iPr2NEt, 160-180 oC, 30 min
2) Pd/C, H2, 45 oC, 1-1.5 min


































aryl	 benzotriazoles,	 many	 suffer	 from	 drawbacks,	 such	 as	 the	 requirement	 for	 harsh	
conditions,	need	for	multiple	steps,	utilization	of	highly	reactive	intermediates	or	starting	
materials	and,	in	some	cases,	the	lack	of		regioselectivity	let	alone	the	issue	of	regiospecificity.			
Given	 these	 considerations,	 we	 were	 interested	 in	 developing	 an	 easy	 and	 regiospecific	
synthesis	 of	 N-aryl	 benzotriazoles	 from	 easily	 accessible	 starting	 materials	 such	 as	 N-
hydroxybenzotriazoles	 and	 arylboronic	 acids.	 	 Our	 idea	 was	 based	 upon	 an	 earlier	
disclosure,	where	we	 had	 shown	 that	N-hydroxybenzotriazoles	 could	 be	 “deoxygenated”	
(reduced)	to	benzotriazoles	with	tetrahydroxydiboron.54		In	that	work	we	had	proposed	a	
plausible	O	 to	N	prototropy	as	being	operational,	which	reveals	an	 intermediate	N-oxide.		





























4	 equiv.	 of	 pyridine.	 	 Reactions	 were	 typically	 run	 in	 a	 10	mL	 round	 bottom	 flask	with	
stirring,	 for	24	hours	 at	 room	 temperature	 (data	 shown	 in	Table	1).	 	We	 screened	 three	
solvents	for	this	reaction,	CH2Cl2,	ClCH2CH2Cl	and	DMSO.		Between	the	three	tested	solvents	











substitute	pyridine	with	Et3N	and	2,2’-dipyridine.	 	The	 results	of	 these	 reactions	 showed	
relatively	low	product	yields,	30%	and	10%,	respectively	(entries	5	and	6).		We	also	found	
that	stoichiometric	amount	of	Cu(OAc)2	was	necessary	for	the	reaction.		When	0.5	equiv.	and	
0.25	 equiv.	 of	 Cu(OAc)2	were	 used	 low	 product	 yields	were	 observed	 (entries	 7	 and	 8).			







Entry					 Conditions	 Solvent	 Yield	(%)b	
1	 pyridine	(4	equiv.),	Cu(OAc)2	(1	equiv.)	 ClCH2CH2Cl	 27c	
2	 pyridine	(4	equiv.),	Cu(OAc)2	(1	equiv.)	 CH2Cl2	 42c	
3	 pyridine	(4	equiv.),	Cu(OAc)2	(1	equiv.)	 DMSO	 NRd	
4	 pyridine	(4	equiv.),	Cu(OAc)2	(1	equiv.)	 CH2Cl2	 77e	
5	 Et3N	(4	equiv.),	Cu(OAc)2	(1	equiv.)	 CH2Cl2	 30e	
6	 2,2’-dipyridine	(2	equiv.),	Cu(OAc)2	(1	equiv.)	 CH2Cl2	 10e	
7	 pyridine	(4	equiv.),	Cu(OAc)2	(0.5	equiv.)	 CH2Cl2	 26e	
8	 pyridine	(4	equiv.),	Cu(OAc)2	(0.25	equiv.)	 CH2Cl2	 14e	
9	 pyridine	(4	equiv.),	CuI	(1	equiv.)	 CH2Cl2	 11e	
10	 pyridine(4	equiv.),	CuCl	(1	equiv.)	 CH2Cl2	 14e	
a	Reactions	were	conducted	with	100	mg	of	BtOH	in	2	mL	of	solvent,	under	a	balloon	filled	
with	O2	gas.			b	Yield	is	of	isolated	and	chromatographically	purified	product.			c	Reaction	using	





product	 of	 the	 reaction	 was	 either	 the	 benzotriazole	 phenyl	 ether	 or	 1-phenyl-1H-
benzotriazole-3-oxide.		It	has	previously	been	reported	by	Lam	et	al.	that	the	reaction	of	1-
hydroxy-1H-benzotriazole	with	 PhB(OH)2	 using	 Cu(OAc)2,	 pyridine	 and	 CH2Cl2	 under	 air	
conditions	resulted	in	formation	of	benzotriazole	phenyl	ether.		To	establish	if	the	reaction	
in	 fact	 leads	 to	 the	 formation	 of	 ether	 and	 not	 1-phenyl-1H-benzotriazole-3-oxide,	 the	
product	 was	 crystallized	 using	 a	 mixture	 of	 CH2Cl2	 and	 hexanes.	 	 Crystallographic	 data	




















yields	 of	 products	 3	 and	4).	 	 Steric	 factors	 became	more	 significant	 in	 the	 case	 of	 the	o-
tolylboronic	acid.		Here	only	14%	yield	of	the	desired	compound	5	was	obtained	as	compared	





































































1: 77% 2: 72% 3: 51% 4: 70%
5: 14% 6: 62% 7: 72% 8: 59%
9: 24% (45%) 10: 73% 11: 37% (47%) 12: 55%
13: 13% (26%) 14: 26% (28%)
 18 
 
(dibenzofuranyl)boronic	 acid	 with	 the	 increased	 amount	 of	 boronic	 acid.	 	 In	 certain	



















































































18: 2 h, 91% 19: 2 h, 94%% 20: 4 h, 88% 21: 2 h, 95%
22: 3 h, 89% 23: 6 h, 79% 24: 2 h, 92% 25: 6 h, 91%
26: 3 h, 89% 27: 2 h, 99% 28: 2 h, 89% 29: 4 h, 89%
30: 4 h, 76% 31: 4 h, 76%
N
NN
















NMR	 spectrum	 for	 the	 already	 reported	 6-chloro-1-(p-tolyl)-1H-benzotriazole.47	 	 The	
spectra	show	significant	differences	and	dissimilarities	in	proton	shifts	indicate	that	the	two	


























the	 modified	 method	 may	 be	 beneficial	 when	 the	 intermediate	 N-oxide	 is	 prone	 to	
degradation.	 	 It	 should	be	noted	 that	 the	 two-step,	 one	pot	 approach	may	not	be	 readily	
applicable	 in	some	cases.	 	For	example,	 in	 reactions,	where	 the	dimeric	byproducts	were	



































Because	 benzotriazole	 derivatives	 are	 known	 to	 possess	 biological	 activity,	 we	
synthesized	 a	 product	 containing	 the	 privileged	 pyrimidine	 motif,	 by	 using	 2-



























arylbenzotriazole	 derivative	 39	 in	 a	 91%	 yield.	 	 This	 compound	 demonstrates	 that	
biologically	important	molecules	can	be	synthesized	via	this	method.		













































In	 conclusion,	 we	 designed	 an	 efficient	 method	 for	 synthesis	 of	 N1-arylated	
benzotriazoles	 from	 hydroxybenzotriazols	 and	 arylboronic	 acids.	 	 A	 wide	 range	 of	
arylboronic	acids	gave	satisfactory	results.		Low	yields	were	recorded	for	the	boronic	acids	
with	ortho	substituents,	where	steric	factor	was	significant,	and	also	for	those	boronic	acids	
that	 contain	 a	 heteroatom	 within	 the	 ring.	 	 In	 most	 of	 the	 low	 yielding	 reactions,	 an	






















In	 a	 clean,	 dry	 10	 mL	 round	 bottom	 flask	 equipped	 with	 a	 stir	 bar	 and	
containing	 20	 mg	 of	 4	 Å	 molecular	 sieves,	 was	 placed	 1-	 hydroxy-1H-
benzotriazole	 (125.1	mg,	1.0	mmol).	 	CH2Cl2	 (2.5	mL)	and	pyridine	 (324	μL,	4.0	mmol,	4	
equiv.)	 were	 added,	 and	 the	 mixture	 was	 stirred	 until	 the	 solid	 dissolved.	 	 Next,	
phenylboronic	acid	(134.1	mg,	1.1	equiv.)	and	Cu(OAc)2	(181.6	mg,	1.0	equiv.)	were	added,	
and	the	mixture	was	stirred	for	24	h	at	room	temperature,	under	an	atmosphere	of	oxygen	











mg,	 1.0	 equiv.)	 and	MeCN	 (250	 μL)	was	 added	 followed	 by	 the	 addition	 of	
B2(OH)4	(23.3	mg,	1.1	equiv.).		The	vial	was	flushed	with	nitrogen	gas	and	heated	at	50	oC	in	
















Compound	 2	 (165.8	 mg	 72%)	 was	 prepared	 from	 the	 corresponding	 1-
hydroxy-1H-benzotriazole	 precursor	 (135.1	 mg,	 1.1	 mmol)	 and	 was	





























benzotriazole	 (135.1	 mg,	 1.1	 mmol)	 and	 was	 obtained	 as	 a	 white,	
crystalline	solid	after	column	chromatography	on	100–200	mesh	silica	by	sequential	elution	
























=	 136.1,	 133.2,	 131.5,	 131.3,	 130.2,	 128.8,	 125.1,	 123.4,	 122.6,	 116.2,	 111.7,	 17.9.	 HRMS	
(ESI/TOF)	m/z	calculated	for	C13H11N3ONa	[M	+	Na]+:	248.0794,	found	248.0798.		
1-(p-Tolyl)-1H-benzotriazole	3-oxide	(6)		












































































































NMR	 (125	MHz,	 CDCl3):	δ	 =	 137.8,	 136.5,	 136.4,	 133.6,	 132.0,	 131.8,	 125.8,	 125.7,	 125.6,	




































Compound	 16	 (205.4	 mg,	 63%	 yield)	 was	 prepared	 from	 the	
















NMR	 (125	MHz,	 CDCl3):	δ	 =	 134.8,	 133.6,	 132.7,	 132.2,	 131.7,	 131.5,	 124.0,	 122.8,	 116.1,	
112.5.	 HRMS	 (ESI/TOF)	 m/z	 calculated	 for	 C12H8BrClN3O	 [M	 +	 H]+:	 323.9534,	 found	
323.9520.		
5-Chloro-1-(p-tolyl)-1H-benzotriazole	3-oxide	(17)		
Compound	 17	 (203.0	 mg,	 78%	 yield)	 was	 prepared	 from	 the	



































































































































































































Compound	 33	 (46.3	 mg,	 76%	 yield)	 was	 prepared	 from	 the	








Compound	 34	 (46.3	 mg,	 87%	 yield)	 was	 prepared	 from	 the	

















































Compound	 37	 (89.2	 mg,	 26%	 yield)	 was	 prepared	 from	 the	
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